Abstract
Forskolin is a labdane diterpene obtained from the plant Coleus Forskohlii. Forskolin probably acts by activation of adenylcylase. Forskolin was infused intravenously in patients with low cardiac output, commencing with 0.1 ug/kg/minute in Hemaccel solution. The rate was doubled every 2 minutes to a maximum of 1.6 ug/kg/Min. Ventricular functions was evaluated by a nuclear stethoscope before infusion and 5, 10, 15 and 50 Minutes after stopping the infusion. The cardiovascular parameters included heart rate, systolic blood pressure, diastolic blood pressure, ejection fraction, cardiac output, peak ejection rate, peak filling time and overall filling time. The ejection fraction, in 8 patients, rose from the mean basal value of 23.10± 2037 to 38±3.59(P< 0.001). There were also significant increases in ejection velocity and filling velocity. These effects were seen at a dose of 8–16 ug/kg/10 minutes. No significant chronotropic or barotropic effects were notedo Forskolin was extremely well tolerated at this dose.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Metzger H. and Lindner F. The Positive Inotropic - Acting Forskolin, a Potent Adenylatecyclase Activato. Arzneimittel-Forschung 31(11)8, 1248–1250 (1981).
Rodger, I.W. and Shahid, M. Forskolin, cyclic nucleotides and positive inotropism in isolated papillary muscles of the rabbit Brit. J. Pharmac 81, 151–159 (1984).
Seamon, K.B. and Daly, J.W. Forskolin: A Unique Diterpene activator of Cyclic AMP-Generating Systems. Journal of Cyclic Nucleotide Res. 7(4) : 201–224 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Nair, K.G., Lele, R.D., Kamdar, N. (1987). Forskolin, A New Inotropic Agent. In: Beamish, R.E., Panagia, V., Dhalla, N.S. (eds) Pharmacological Aspects of Heart Disease. Developments in Cardiovascular Medicine, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2057-9_29
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2057-9_29
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9222-7
Online ISBN: 978-1-4613-2057-9
eBook Packages: Springer Book Archive